Skip to content
Sub practice
Sub practice

Joint Ventures

We are specialists in joint ventures and strategic alliances.

Our Corporate Finance practice specialises in advising on joint ventures and strategic alliances. As a core part of our offering, we support investors and entrepreneurs, advising them on structuring, drafting and negotiating joint venture agreements.

Because we work collaboratively across all our practice groups, we also offer a broad range of supporting advice in areas such as intellectual property rights and exploitation, regulation and licensing, antitrust, commercial agreements, real estate, tax, employment and benefits. We have experience in advising on a wide range of joint venture structures and can advise on the commercial and strategic issues involved, as well as dealings with local regulators.

We have acted on a significant number of joint ventures for corporates, international investment houses and banks across the globe. Our clients entrust us with their highest profile work in this area and your Allen & Overy team will draw on this experience and know-how to deliver commercial and cost effective advice.

News and insights

Vertical perspective of New York City skyline

Publications: 05 April 2024

National Security Division Announces New Self-Disclosure Policy in M&A Transactions

The National Security Division (NSD) of the Department of Justice announced a new self-disclosure policy on March 7, 2024 (M&A Policy) that impacts corporations, private equity firms, and venture…

Read more
Light trails of cars at night

Publications: 05 October 2023

Funds use range of techniques to fill funding gaps and navigate M&A valuation mismatches

From NAV financings to preferred equity, holdco PIK financings and partial sales, sponsors are finding creative ways to navigate current market volatility. Here we explain what to look out for in…

Read more
Heap of medical pills in white, blue and other colors. Pills in plastic package. Concept of healthcare and medicine.

Blog Post: 04 January 2023

Why AI drug discovery deals are different from traditional pharma collaborations

Pharma companies have been working with artificial intelligence (AI) for a decade or more. As the cost and time of bringing a new drug to market continues to rise, pharma companies are increasingly…

Read more

Publications: 20 December 2022

Why AI drug discovery deals are different from traditional pharma collaborations

Pharma companies have long collaborated with other organisations to bring new drugs to market. But what happens when their partner is an artificial intelligence (AI) company rather than another pharma…

Read more

Recognition

Download our practice brochure

Blue and black triangles

Our Corporate Finance practice specialises in advising on joint ventures and strategic alliances. As a core part of our offering, we support investors and entrepreneurs, advising them on structuring, drafting and negotiating joint venture agreements.